Abstract
Interleukin-3 (IL-3) is a hemopoietic growth factor involved in the survival, proliferation and differentiation of multipotent hemopoietic cells. In five mammalian species, including man, the gene encoding IL-3 has been isolated and expressed to yield the mature recombinant proteins. The human IL-3 gene encodes a protein of 133 amino acids with two conserved cysteine residues and 2 potential N-linked glycosylation sites; human native IL-3 has not been characterized. Comparison of the IL-3 genes revealed a more rapid evolutionary divergence than has been observed for other hemopoietic growth factors, and, hence, a more pronounced species specificity of the functional proteins was found. In agreement with its stimulatory action on immature multipotent cells, thein vivo actions of homologous recombinant IL-3 in nonhuman primates include a highly increased production of blood cells along the neutrophilic, eosinophilic and basophilic granulocyte as well as the monocyte, red cell and platelet lineages.
Similar content being viewed by others
References
Metcalf D. The granulocyte-macrophage colony-stimulating factors. Science 1985; 229: 16–22.
Metcalf D. The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors. Blood 1986; 67: 257–67.
Clark SC, Kamen R. The human hematopoietic colonystimulating factors. Science 1987; 236: 1229–37.
Ihle JN, Keller J, Orozslan S, Henderson LE, Copeland TD, Fitch F, Prystowski MB, Goldwasser E, Schrader JW, Palaszynski E, Dy M, Lebel B. Biological properties of homogeneous interleukin-3. J Immunol 1984; 131: 282.
Fung MC, Hapel AJ, Ymer S, Cohen DR, Johnson RM, Campbell HD, Young IG. Molecular cloning of cDNA for mouse interleukin-3. Nature 1984; 307: 233.
Suda J, Suda T, Kubota K, Ihle JN, Saito M, Miura Y. Purified interleukin-3 and erythropoietin support the terminal differentiation of hemopoietic progenitors in serumfree culture. Blood 1986; 67: 1002.
Ishibashi T, Burstein SA. Interleukin-3 promotes the differentiation of isolated single megakaryocytes. Blood 1986; 67: 1512.
Dorssers L, Burger H, Bot F, Delwel R, Geurts van Kessel B, Löwenberg B, Wagemaker G. Characterization of a human multilineage colony-stimulating factor cDNA clone identified by a conserved noncoding sequence in mouse interleukin-3. Gene 1987; 55: 115.
Bot FJ, Dorssers L, Wagemaker G, Löwenberg B. Stimulating spectrum of human recombinant multi-CSF (IL-3) on human marrow precursors: importance of accessor cells. Blood 1988; 71: 1609.
Palacios R, Henson G, Steinmetz M, McKearn JP. Interleukin-3 supports growth of mouse pre-B-cell clonesin vitro. Nature 1984; 309: 126.
Djeu JY, Lanza E, Pastore S, Hapel AJ. Selective growth of natural cytotoxic but not natural killer effector cells of interleukin-3. Nature 1983; 306: 788.
Scheven BAA, Visser JWM, Nijweide PJ.In vitro osteoclast generation from different bone marrow fractions, including a highly enriched haematopoietic stem cell population. Nature 1986; 321: 79.
Delwel R, Dorssers L, Touw I, Wagemaker G, Löwenberg B. Human recombinant multilineage colony stimulating factor (interleukin-3): stimulator of acute myelocytic leukemia progenitor cellsin vitro. Blood 1987; 70: 333.
Mulder AH, Visser JWM, van den Engh GJ. Thymus regeneration by bone marrow suspensions differing in the potential to form early and late spleen colonies. Exp Hemat 1987; 15: 99.
Ihle JN, Keller J, Greenberger JS, Henderson L, Yetter RA, Morse HC. Phenotypic characteristics of cell lines requiring interleukin-3 for growth. J Immunol 1982; 129: 1377.
Ihle JN, Keller J, Henderson L, Klein F, Palaszynski E. Procedures for the purification of interleukin-3 to homogeneity. J Immunol 1982; 129: 2431.
Cerny J. Stimulation of bone marrow haemopoietic stem cells by a factor from activated T cells. Nature 1974; 240: 63.
Wagemaker G. Early erythropoietin-dependent stage ofin vitro erythropoiesis: relevance to stem cell differentiation. In: Baum SJ, Ledney GD, van Bekkum DW. eds. Experimental hematology today. Basel: S. Karger, 1980: 47.
Dorssers L, Burger H, Wagemaker G. Identity of murine stem cell activating factor and interleukin-3 and common specificity for pluripotent stem cells. Exp Hemat 1984; 12: 357.
Ymer S, Tucker WOJ, Anderson CJ, Hapel AJ, Campbell HD, Young LG. Constitutive synthesis of interleukin-3 by leukaemia cell line WEHI-3B is due to retroviral insertion near the gene. Nature 1985; 317: 255–8.
Kindler V, Thorens B, De Kossodo S, Allet B, Eliason JF, Thatcher D, Farber N, Vassali P. Stimulation of hematopoiesisin vivo by recombinant bacterial murine interleukin-3. Proc Natl Acad Sci USA 1986; 83: 1001.
Metcalf D, Begley CG, Johnson GR, Nicola NA, Lopez AF, Williamson DJ. Effects of purified bacterially synthesized murine multi-CSF (IL-3) on hematopoiesis in normal adult mice. Blood 1986; 68: 46.
Wong PMC, Chung S-W, Dunbar CA, Bodine DM, Ruscetti S, Nienhuis AW. Retrovirus mediated transfer and expression of the interleukin-3 gene in mouse hematopoietic cells results in a myeloproliferative disorder. Mol Cell Biol 1989; 9: 798.
Zipori D, Lee F. Introduction of Interleukin-3 gene into stromal cells from the bone marrow alters hemopoietic differentiation but does not modify stem cell renewal. Blood 1988; 71: 586–96.
Cohen DR, Hapel AJ, Young IG. Cloning and expression of the rat interleukin-3 gene. Nucl Acids Res 1986; 14: 3642–58.
Emerson SG, Sieff CA, Wang GC, Wong GG, Clark SC, Nathan DG. Purification of fetal hematopoietic progenitors and demonstration of recombinant multipotential colony-stimulating activity. J Clin Invest 1985; 76: 1286–90.
Yang, Y-C, Ciarletta AB, Temple PA, Chung MP, Kovacic S, Witek-Giannotti JA. S, Leary AC, Kriz R, Donahue RE, Wong GC, Clark SC. Human IL-3 (Multi-CSF): identification by expression cloning of a novel hemopoietic growth factor related to murine IL-3. Cell 1986; 47: 3–10.
Shaw G, Kamen R. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 1989; 245: 852.
Van Leeuwen BH, Martinson ME, Webb GC, Young IG. Molecular organization of the cytokine gene cluster, involving human IL-3, IL-4, IL-5 and GM-CSF, on human chromosome 5. Blood 1989; 73: 1142–8.
Yang YC, Kovavic S, Kriz R, Wolf S, Clark SC, Wellems TE, Nienhuis A, Epstein N. The human gene for GM-CSF and IL-3 are closely linked in tandem on chromosome 5. Blood 1988; 71: 958–61.
Burger H, van Leen RW, Dorssers LCJ, Persoon NLM, Wagemaker G. Species specificity of human interleukin-3 demonstrated by cloning and expression of the homologous rhesus monkey (Macaca mulatta) gene. Submitted for publication.
Donahue RE, Seehra J, Metzger M, Lefebvre D, Rock B, Carbone S, Nathan DG, Garnick M, Sehgal PK, Laston D, LaVallie E, McCoy J, Schendel FPF, Norton C, Turner K, Yang Y-C, Clark SC. Human IL-3 and GM-CSF act synergistically in stimulating hematopoiesis in primates. Science 1988; 241: 1820–3.
Krumwieh D, Seiler F.In vivo effects of recombinant colony stimulating factors on hematopoiesis in cynomolgus monkeys. Transplant Proc 1989; 21: 2964–67.
Mayer P, Valent P, Schmidt G, Liehl E, Bettelheim P. Thein vivo effects of recombinant human interleukin-3: demonstration of basophil differentiation factor, histamine-producing activity and priming of GM-CSF-responsive progenitors in nonhuman primates. Blood 1989; 74: 613–21.
Wagemaker G, van Gils FCJM, Burger H, Dorssers LCJ, van Leen RW, Persoon NLM, Wielenga JJ, Heeney JL, Knol E. Highly increased production of bone marrow derived blood cells by administration of homologous interleukin-3 to rhesus monkeys. Blood, in press.
Byron JW. Pharmacodynamic basis for interaction of cimetidine with bone marrow stem cells (CFU-S). Exp Hemat 1980; 8: 256.
Dye M, Schneider E, Piquet-Pellorce C, Lebel B, Minkowski M, Kindler V, Luffau G. In: Lymphokine Receptor Interactions (Eds. D. Fradelizi, J. Bertoglio), Colloque INSERM/John Libbey Eurotex Ltd, 1989; 179: 243.
Lopez AF, Eglinton JM, Gillis D, Park LS, Clark S and Vadas MA. Reciprocal inhibition of binding between interleukin-3 and granulocyte-macrophage colony-stimulating factor to human eosinophils. Proc Natl Acad Sci USA 1989; 86: 7022–6.
Lopez AF, Dyson PG, To LB, Elliot MJ, Milton SE, Russell JA, Juttner CA, Yang Y-C, Clark SC, Vadas MA. Recombinant human interleukin-3 stimulation of hematopoiesis in human: loss of responsiveness with differentiation in the neutrophilic myeloid series. Blood 1988; 72: 1797–804.
Valent P, Besemer J, Muhm M, Madjics O, Lechner K, Bettelheim P. Interleukin-3 activates human blood basophils via high-affinity binding sites. Proc Natl Acad Sci 1989; 86: 5542–6.
Ganser A, Lindemann A, Ottman OG, Hermann F, Schulz G, Mertelssmann R, Hoelzer D. Effect of recombinant human interleukin-3in vivo. A phase I trial. Exp Hemat 1989; 17: 484.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wagemaker, G., Burger, H., van Gils, F.C.J.M. et al. Interleukin-3. Biotherapy 2, 337–345 (1990). https://doi.org/10.1007/BF02170083
Issue Date:
DOI: https://doi.org/10.1007/BF02170083